Industry Funding of Cancer Patient Advocacy Organizations (Mayo/Medscape) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present


Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, November 16, 2016

Industry Funding of Cancer Patient Advocacy Organizations (Mayo/Medscape)

  November 16, 2016
In the new analysis, 51 of the 68 PAOs (75.0%) disclosed their sponsors. Sixteen PAOs (23.5%) did not report whether they had biopharmaceutical sponsorship. The fact that nearly 25% of the PAOs were lacking sponsor disclosures is problematic, say the authors.
"This study may underestimate sponsorship because 23.5% of the PAOs neither acknowledged funding nor a policy precluding it," they write.
  Their new study was published in the November issue of the Mayo Clinic Proceedings.
 Article Outline
 Only one of the POAs, the Inflammatory Breast Cancer Research Foundation, explicitly reported that it does not accept money from drug companies.
 Table. PAOs by Cancer Subtypes (Recommended by NCCN)


Post a Comment

Your comments?